StockData
Elevance Health, Inc. logo

Elevance Health, Inc.

ELVNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Oct 21, 2026Score 15/3014% below fair value
$413.60−6.47 (-1.54%)

Close on Nov 2, 2026Market cap $89.70BP/E 18.4Yield –

Elevance Health Income Before Income Tax Expense by Year

Income Before Income Tax Expense (GAAP Pretax Income) ($M)

QuarterlyAnnual

Elevance Health Income Before Income Tax Expense: $6,710M in FY2025, down 15.1% from a year earlier.

Latest, FY2025
6,710
Period ended Dec 31, 2025
Change on a year earlier
-15.1%
7,904 in FY2024
History
12 years
Since FY2014
Sources
2
Documents cited below

Where the FY2025 figure comes from

“us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest (2025-12-31): 6,710,000,000.00”

Source: ELV 10-K (XBRL us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest) ↗

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedIncome Before Income Tax Expense (GAAP Pretax Income) ($M)Year on yearSource
FY2025Dec 31, 20256,710-15.1%ELV 10-K (XBRL us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest) ↗
FY2024Dec 31, 20247,904+2.4%ELV 10-K (XBRL us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest) ↗
FY2023Dec 31, 20237,715+1.5%ELV 10-K (XBRL us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest) ↗
FY2022Dec 31, 20227,600-4.9%ELV 10-K (XBRL us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest) ↗
FY2021Dec 31, 20217,995+28.2%ELV 10-K (XBRL us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest) ↗
FY2020Dec 31, 20206,238+4.2%ELV 10-Q (XBRL us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest) ↗
FY2019Dec 31, 20195,985+18.1%ELV 10-K (XBRL us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest) ↗
FY2018Dec 31, 20185,068+27.9%ELV 10-K (XBRL us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest) ↗
FY2017Dec 31, 20173,964-13.0%ELV 10-K (XBRL us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest) ↗
FY2016Dec 31, 20164,555-1.6%ELV 10-K (XBRL us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest) ↗
FY2015Dec 31, 20154,631+6.0%ELV 10-K (XBRL us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest) ↗
FY2014Dec 31, 20144,368–ELV 10-K (XBRL us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest) ↗

Cite this data

StockData. (2026). Elevance Health Income Before Income Tax Expense ($M), annual FY2014–FY2025 [Data set]. Compiled from Elevance Health SEC filings and investor materials. https://stockdatahq.com/stocks/elv/kpis/fin-pretax-income

See every metric in the Elevance Health KPI table. Data updated Oct 28, 2026.